-
Evaluation of commercial Guardant360 ctDNA test in metastatic prostate cancer
Study
EGAS00001003352
-
Exploration of coding and non-coding variants in cancer using GenomePaint.
Study
EGAS00001004669
-
mutational landscape of normal human breast
Study
EGAS00001004672
-
Res1_HT29_exp1_MC_02_03_22
Study
EGAS00001006092
-
Genomics to select patients with metastatic breast cancer for targeted therapy (microarray_oncoscan)
Study
EGAS00001005586
-
Molecular analysis of FIT interval colorectal cancers
Study
EGAS00001004683
-
Genomics to select patients with metastatic breast cancer for targeted therapy (microarray_agilent)
Study
EGAS00001005587
-
Human pan-cancer plasma cfRNA study - raw data
Study
EGAS00001006755
-
Allele-specific expression of GATA2 due to epigenetic dysregulation in double mutated CEBPA AML
Study
EGAS00001004684
-
Long-read sequencing of diagnosis and post-therapy medulloblastoma reveals complex rearrangement patterns and epigenetic signatures
Study
EGAS00001006576
-
Regulatory T cell transcriptomic reprogramming characterizes adverse events by checkpoint inhibitors in solid tumors
Study
EGAS00001004694
-
A comprehensive characterization of the cell-free transcriptome reveals tissue- and subtype-specific biomarkers for cancer detection
Study
EGAS00001004704
-
Whole genome sequencing of EBV Associated Nasopharyngeal Carcinoma
Study
EGAS00001004705
-
A novel orthotopic patient-derived xenograft model of radiation-induced glioma following medulloblastoma
Study
EGAS00001004709
-
Organoid_Derivation_Project___GRCh38___WGS
Study
EGAS00001004712
-
Genomic and transcriptomic determinants of therapy resistance and immune landscape evolution during anti-EGFR treatment in colorectal cancer
Study
EGAS00001003367
-
Microbiota 16S sequencing study in NSCLC patients eligible for surgery without neoadjuvant treatment
Study
EGAS00001004728
-
Real-time analysis of the cancer genome and fragmentome from plasma and urine short and long cell-free DNA using Nanopore sequencing
Study
EGAS00001006591
-
The genomic landscape of serrated lesion of the colorectum
Study
EGAS00001005648
-
Mutation-specific non-canonical pathway of PTEN as a distinct therapeutic target for glioblastoma
Study
EGAS00001004753
-
Genomics-based personalized oncology in cancer of unknown primary (CUP, project H021)
Study
EGAS00001004786
-
Comprehensive genomic and transcriptomic analysis of three synchronous primary tumours and a recurrence from a head and neck cancer patient
Study
EGAS00001004857
-
UROMOL 2020 - SNP data
Study
EGAS00001004862
-
Combined MEK and BCL-2/XL inhibition is effective in high-grade serous ovarian cancer patient-derived xenograft models and BIM levels are predictive of responsiveness
Study
EGAS00001003427
-
Proteogenomics of chronic lymphocytic leukemia
Study
EGAS00001005746
-
Accurate detection of tumor-specific fusion genes reveals strongly immunogenic personal neo-antigens
Study
EGAS00001004877
-
Single_cell_characterization_of_T_cell_lymphoma_
Study
EGAS00001005750
-
Clinical genome sequencing uncovers potentially targetable truncations and fusions of MAP3K8 in spitzoid and other melanomas
Study
EGAS00001003430
-
Somatic_mutation_and_clonal_evolution_in_the_human_bladder_Novaseq
Study
EGAS00001003433
-
Whole-exome sequencing of paired tumour/blood of 58 T1 stage bladder cancer patients
Study
EGAS00001005765
-
Functional and genomic heterogeneity of long-term self-renewing compartment as the origin of treatment resistance in pancreatic tumors
Study
EGAS00001003442
-
Exome sequencing from cfDNA blood samples. 159 samples at 2x101bp Illumina reads in Fastq format.
Study
EGAS00001006656
-
Analysis of error profiles in deep next-generation sequencing data
Study
EGAS00001003444
-
MCO colorectal cancer genomics at UNSW
Study
EGAS00001003450
-
Defining structural variation associated with breast cancer susceptibility by long-read genome sequencing
Study
EGAS00001005872
-
Comprehensive characterization of pre- and post-treatment samples of breast cancer reveal potential mechanisms of chemotherapy resistance
Study
EGAS00001005876
-
Clonal somatic copy number altered driver events inform drug sensitivity in high-grade serous ovarian cancer
Study
EGAS00001006200
-
WXS and RNA-seq for 22 patients treated with radiation + immunotherapy
Study
EGAS00001006212
-
Adenoma to Carcinoma transition in Colorectal Cancer
Study
EGAS00001003468
-
Dedifferentiated_Melanoma
Study
EGAS00001003471
-
Exome sequencing of synchronous colorectal cancers
Study
EGAS00001003474
-
RNA-seq on patient-derived, stage II, CRC cell lines
Study
EGAS00001005948
-
The Proteogenomic Subtypes of Acute Myeloid Leukemia
Study
EGAS00001005950
-
RNA-sequencing data from metastatic Castration-Resistant Prostate Cancer (mCRPC)
Study
EGAS00001005954
-
MutWP5__CRUK_Mutographs_of_Cancer__BRCA_Carriers___WG__Novaseq_
Study
EGAS00001003523
-
An Isogenic Cell Line Panel for Sequence-based Screening of Targeted Anti-cancer Drugs
Study
EGAS00001005974
-
Combined gene expression and digital pathology identifies molecular mediators of T cell exclusion and immune suppression in ovarian cancer
Study
EGAS00001003487
-
Characterization of MCSP+ melanoma DCC and MelDCC lines
Study
EGAS00001006702
-
Specific BRCA and immune configurations determine optimal response to platinum-based chemotherapy in triple negative breast and ovarian carcinomas (COH_TNBC_RNAseq)
Study
EGAS00001006002
-
Single cell RNA sequencing of colorectal cancer patients (CRC-SG1)
Study
EGAS00001006013